Deva Holding AS
IST:DEVA.E

Watchlist Manager
Deva Holding AS Logo
Deva Holding AS
IST:DEVA.E
Watchlist
Price: 60.55 TRY -0.57%
Market Cap: 12.1B TRY

Gross Margin
Deva Holding AS

36.4%
Current
46%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
36.4%
=
Gross Profit
6B
/
Revenue
16.5B

Gross Margin Across Competitors

No Stocks Found

Deva Holding AS
Glance View

Market Cap
12.1B TRY
Industry
Pharmaceuticals

Deva Holding AS engages in the production and marketing of human pharmaceuticals and raw materials. The firm has four production facilities in Turkey. Its production facilities include the Tokapi, Cerezkoy I, Cerezkoy II and Kartepe production plants. The Company’s product portfolio comprises 73 drugs, which are available on the market in 177 various forms. The company offers products, such as Azitro, Alemax, Cefax, Inhibace, Imatis, Hydrea, Kardozin, Kristapen, Magcar, Magnesie Calcinee, Nostil, Oceral, Remidon, Prolixin and Quet, among others. The firm has two subsidiaries, namely Vetaa Veteriner ve Tarim Ilaclari A.S. and Deva Holding NZ Ltd.

DEVA.E Intrinsic Value
HIDDEN
Show
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
36.4%
=
Gross Profit
6B
/
Revenue
16.5B
What is the Gross Margin of Deva Holding AS?

Based on Deva Holding AS's most recent financial statements, the company has Gross Margin of 36.4%.

Back to Top